Literature DB >> 10805119

Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment.

I Ak1, M P Stokkel, W Bergman, E K Pauwels.   

Abstract

Cutaneous melanoma is a highly malignant tumour of the melanocytes presenting characteristic metabolic and biological features. Early detection decreases mortality and morbidity and provides the best chance for optimal clinical management. Imaging techniques, including scintigraphy, have assumed an important role in detection strategies. As a functional modality, nuclear medicine offers a variety of possibilities to assist in the clinical management of malignant melanoma. This review discusses the clinical aspects and treatment of melanoma, and the imaging techniques used for its diagnosis, staging and follow-up. A survey of currently available techniques is presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805119     DOI: 10.1007/s002590050529

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  4 in total

1.  A new animal model for the imaging of melanoma: correlation of FDG PET with clinical outcome, macroscopic aspect and histological classification in Melanoblastoma-bearing Libechov Minipigs.

Authors:  Raphaël Boisgard; Silvia Vincent-Naulleau; Jean-Jacques Leplat; Stephan Bouet; Catherine Le Chalony; Yves Tricaud; Vratislav Horak; Claudine Geffrotin; Gérard Frelat; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-08       Impact factor: 9.236

2.  Plasma markers for identifying patients with metastatic melanoma.

Authors:  Harriet M Kluger; Kathleen Hoyt; Antonella Bacchiocchi; Tina Mayer; Jonathan Kirsch; Yuval Kluger; Mario Sznol; Stephan Ariyan; Annette Molinaro; Ruth Halaban
Journal:  Clin Cancer Res       Date:  2011-04-12       Impact factor: 12.531

3.  Breast metastasis from melanoma mimicking inflammatory breast cancer.

Authors:  A Martínez-Esteve; R M Álvarez-Pérez; L Caballero-Gullón; M P Sancho-Márquez; I Borrego-Dorado
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-10       Impact factor: 9.236

4.  Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.

Authors:  B Szende; A Horváth; G Bökönyi; G Kéri
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.